<div id="readability-page-1"><p><span>Intuitive Surgical (NASDAQ:ISRG - Get Free Report)</span> had its price objective upped by Wells Fargo &amp; Company  from $600.00 to $654.00 in a report issued on Friday,MarketScreener reports. The brokerage currently has an &#34;overweight&#34; rating on the medical equipment provider's stock. Wells Fargo &amp; Company's target price indicates a potential upside of 19.48% from the company's previous close.</p><div><p><span></span><span>Get <strong>Intuitive Surgical</strong> alerts:</span></p></div><ul><li>$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS</li></ul><p>A number of other brokerages also recently issued reports on ISRG. Leerink Partners upped their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the company an &#34;outperform&#34; rating in a research note on Wednesday, October 22nd. Sanford C. Bernstein  restated an &#34;outperform&#34; rating and set a $685.00 price target on shares of Intuitive Surgical in a research report on Tuesday, October 21st. BTIG Research raised their price objective on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a &#34;buy&#34; rating in a report on Wednesday, October 22nd. Weiss Ratings  reaffirmed a &#34;hold (c)&#34; rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Finally, Hsbc Global Res upgraded shares of Intuitive Surgical to a &#34;strong-buy&#34; rating in a research note on Thursday, October 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have assigned  a Hold rating and one  has issued  a Sell rating to the company. According to MarketBeat, the stock  has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $608.79.</p><p><b>View Our Latest Research Report on Intuitive Surgical</b></p><h2>Intuitive Surgical Stock Performance</h2><ul><li>Top 3 Stocks Powering Through Trump’s Tariff Policies</li></ul><p>NASDAQ:ISRG opened at $547.36 on Friday. Intuitive Surgical has a 52 week low of $425.00 and a 52 week high of $616.00. The firm has a 50-day moving average price of $527.82 and a two-hundred day moving average price of $505.98. The firm has a market cap of $196.22 billion, a price-to-earnings ratio of 72.40, a price-to-earnings-growth ratio of 5.11 and a beta of 1.68. </p><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical's quarterly revenue was up 22.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.84 earnings per share.  As a group, sell-side analysts forecast that  Intuitive Surgical will post 6.43 earnings per share for the current year. </p><h2>Insider Activity</h2><ul><li>Why Intuitive Surgical Is a No-Brainer for Long-Term Investors</li></ul><p>In related news, insider Gary S. Guthart sold 28,800 shares of the firm's stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.56, for a total value of $15,769,728.00. Following the completion of the transaction, the insider directly owned 27,027 shares of the company's stock, valued at approximately $14,798,904.12. This trade represents a 51.59% decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of the business's stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. The trade was a 9.47% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 109,043 shares of company stock valued at $60,816,225. 0.70% of the stock is currently owned by corporate insiders. </p><h2>Hedge Funds Weigh In On Intuitive Surgical</h2><p>Several hedge funds have recently made changes to their positions in ISRG. Alecta Tjanstepension Omsesidigt boosted its stake in  Intuitive Surgical by 25.4% in the 3rd quarter. Alecta Tjanstepension Omsesidigt now owns 212,800 shares of the medical equipment provider's stock worth $95,160,000 after purchasing an additional 43,100 shares during the period.  Saranac Partners Ltd purchased a new stake in shares of  Intuitive Surgical in the third quarter worth about $4,325,000.  Swiss Life Asset Management Ltd boosted its position in shares of  Intuitive Surgical by 7.7% in the third quarter. Swiss Life Asset Management Ltd now owns 67,483 shares of the medical equipment provider's stock valued at $30,180,000 after acquiring an additional 4,824 shares during the period.  Cambria Investment Management L.P. bought a new position in shares of  Intuitive Surgical in the third quarter valued at approximately $318,000.  Finally, KERR FINANCIAL PLANNING Corp purchased a new position in  Intuitive Surgical during the third quarter valued at approximately $33,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors. </p><h2>About Intuitive Surgical</h2> (Get Free Report)<p>Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.</p><h2>See Also</h2><ul><li>Five stocks we like better than Intuitive Surgical</li><li>Why Are Stock Sectors Important to Successful Investing?</li><li>4 Canadian Oil Stocks That Are Filling the Heavy Crude Gap</li><li>What is a support level?</li><li>Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul</li><li>Best Energy Stocks - Energy Stocks to Buy Now</li><li>3 Recently Downgraded Stocks to Avoid in 2026</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2><p>Before you consider Intuitive Surgical, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ISRG

<p>Wells Fargo & Company raised its target price for Intuitive Surgical (NASDAQ:ISRG) from $600 to $654, maintaining an "overweight" rating, indicating a potential upside of 19.48%. Other brokerages also adjusted their price targets, with a consensus rating of "Moderate Buy" and a target price of $608.79. Intuitive Surgical reported strong quarterly earnings, beating estimates, and insiders have recently sold shares. Hedge funds have adjusted their positions in the company.</p>

Wells Fargo & Company Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price